
COVID BF.7 IN INDIA :
The Omicron sub-variant BF.7 is thought to be contributing to the current COVID outbreak in a number of countries, including China. India has also reported cases of this variant in various states, including Gujarat and Odisha. While the BF.7 strain has not had the same impact in India as it has in China, the government has advised all states and union territories to increase genome sequencing and exercise caution.
Coronavirus Omicron variant:
discovered South Africa in November 2021 and quickly spread around the world in less than a month and a half. The BA.1 variant was discovered first in India, followed by the BA.2 variant, which caused the third wave in January-February 2022. Since then, the offspring of the BA.2 variant have circulated in India without causing significant outbreaks. When the subsequent BA.5 version of Omicron affected Western countries, many parts of India did not see a corresponding increase in cases linked to BA.5.
India:
India has reported four cases of Covid-19 caused by the BF.7 variant since July. According to sources, three cases have been recorded from Gujarat, and one case has also been confirmed in Odisha. They said that all four patients either had no symptoms or only mild symptoms and made a full recovery.
First case:
In the first occurrence, a 60-year-old man from Ahmedabad tested positive for Covid, and his sample included the sub-variant BF.7, according to a report from July. He had a cough and a little fever, according to the state health agency. A 57-year-old guy from the Sola region was the subject of the second case in Ahmedabad.
The BF.7 sub-variant was discovered in Odisha, according to the officials, in a 57-year-old woman who underwent the Covid test because she needed to fly to the US. They declared that she had no symptoms. According to experts, while the sub-variant is to blame for an increase in new Covid cases in nations like China, Japan, and South Korea, it would take some time for India to evaluate its effects. According to Dr. N K Mehra, an emeritus scientist at the ICMR, "BF.7 has a reproduction value of more than 10, meaning an individual infected by the variety can infect at least 10 others," adding that so far there hasn't been a noticeably increased number of cases.
SYMPTOMS:
Omicron is currently the most prevalent variation worldwide, so we should be aware of the symptoms this strain may produce. ndiaaseportedoeid-
Joint pain
Upper body pain
URI (upper respiratory infection)
Vertigo
Sore throat
Runny nose
Fever
Cough with or without phlegm
Headache
Hoarse voice
Muscle pain and body aches
Altered sense of smell
Treatment, Remedies, Precautions
A new strain known as BF 7 poses a threat to all Indian citizens as well as people anywhere else. Get the booster dose of the Covid 19 BF.7 vaccine if you experience any of the symptoms listed above. You should get over to the nearby Covid Vaccination Center as soon as possible to acquire a booster dose so that you can protect yourself. To be protected from this variation, be sure to carry your E Aadhar Card or a hard copy of your Aadhar Card.
There are numerous Covid BF 7 Variant Precautions that you must observe, and the most important ones are covered in this post.
The first need is that everyone present must have received the Covid Vaccine in both recommended dosages and the booster dose.
Second, while visiting outside the home, you must always wear the mask and periodically sanitise your hands.
Consume the nutrients and build your immunity to protect yourself from the various Coronavirus types.
To avoid contracting the infection, keep social distance in all public settings and stay away from crowds.
Increase your immunity by consuming nutrients like as almonds, apricots, and other foods to defend yourself from this version as a first-line home remedy.
Second, you must have received all Covid Vaccine doses, including doses 1 and 2.
People who have taken both doses should additionally administer the booster dosage.
In addition, keep your family safe by regularly checking for fever and other diseases.

Comments
There are no comments for this story
Be the first to respond and start the conversation.